COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67

収録刊行物

• Cancer Epidemiol.

  Cancer Epidemiol. 34 316-322, 2010